Ear nerve stimulation device for teens with stomach pain from gut-brain disorders
Tests an ear-worn stimulation device in teens with gut-brain related abdominal pain.
Key facts
- Who runs it
- Nationwide Children's Hospital
- Where
- Columbus, United StatesSee the site
- Trial code
- Registry title
- Transauricular Neurostimulation for Abdominal Pain Due to DGBI
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 23 Oct 2025
- Planned end
- 30 Oct 2026
- Type of study
- Interventional
- Treatments tested
- Transcutaneous auricular neurostimulation
- Record updated
- 1 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for teens aged 12 to 18 with belly pain from a gut-brain disorder (such as irritable bowel syndrome). They will use an ear nerve-stimulation device daily for 4 weeks.
- Age
- 12 to 18 years
- Sex
- All sexes
- Disease stage
- Belly pain linked to a disorder of gut-brain interaction (DGBI) diagnosed by Rome IV criteria. Average pain must be 3 or more on a 0-10 scale, on at least 2 days per week.
- Earlier treatment
- Medicines for belly pain or gut symptoms must not have changed in the 2 weeks before joining. Doses must be stable for at least 2 weeks.
Main reasons for not taking part
- A medical or mental health condition that makes ear nerve stimulation unsafe
- Ear shape that stops the Sparrow earpiece from fitting on the left ear
- Developmental delay
- An implanted electronic device or a hearing aid
- Pregnancy, being in another treatment trial, being unable to communicate in English, or being a prisoner
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age 12-18 years
- Clinical diagnosis of an abdominal pain-related disorder of gut-brain interaction (DGBI) meeting Rome IV criteria
- Average abdominal pain intensity ≥3 on a 0-10 scale and pain on at least 2 days per week
- Proper fit of the Sparrow earpiece on the left ear, as determined by study personnel
Who cannot take part
- Change in medications used to treat abdominal pain or gastrointestinal symptoms within 2 weeks before enrollment. Participants must be on stable doses for at least 2 weeks before enrollment
- Medical or psychiatric condition that contraindicates transauricular neurostimulation or creates a safety risk
- Abnormal ear anatomy preventing earpiece placement
- Developmental delay
- Implanted electronic device or hearing aid
- Participation in another interventional trial
- Pregnancy
- Unable to communicate in English
- Prisoner
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 18 years old?
Where in United States
- Nationwide Children's HospitalColumbus, United StatesContact: Peter Lu, MDTaking people
About the trial
What the trial wants to find out
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.
The group in the trial
- Transauricular neurostimulationTreatment being tested
All participants receive active transcutaneous auricular neurostimulation using the Sparrow Link device for at least one hour daily for 4 weeks, with follow-up assessments through week 8.
Treatment: Transcutaneous auricular neurostimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Transauricular Neurostimulation for Irritable Bowel Syndrome
- Plain-language title
- Ear nerve stimulation device for teens with stomach pain from gut-brain disordersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07798180, who can take part
- Record updated
- 1 September 2026